>
>
Swine Vaccines Market – By Product (Inactivated, Live attenuated, Recombinant, Subunit Vaccines), Disease Type (Porcine Reproductive & Respiratory Syndrome, Porcine Circovirus Type 2, Mycoplasma Hyopneumoniae), End-user, Global Forecast 2024 – 2032
Download Free PDF

Swine Vaccines Market
Get a free sample of this reportGet a free sample of this report Swine Vaccines Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 12
Tables & Figures: 226
Countries covered: 22
Pages: 126
Download Free PDF
Swine Vaccines Market Size
Swine Vaccines Market size was valued at USD 1.6 billion in 2023 and is expected to exhibit growth at a CAGR of 5.3% from 2024 to 2032. The increasing prevalence of swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Type 2 (PCV2), and African Swine Fever (ASF) compels farmers to adopt vaccination programs to prevent devastating outbreaks. This surge in disease prevalence significantly drives the growth of the market.
Additionally, technological advancements in vaccine development, such as recombinant and DNA vaccines, enhance efficacy and safety, making them more appealing to swine producers and further fueling market growth. Furthermore, government initiatives and support for vaccination programs, coupled with improved veterinary services and distribution networks, facilitate market expansion. Additionally, heightened awareness about animal healthcare and welfare among farmers leads to greater vaccine adoption, reinforcing the market's upward trajectory.
Swine vaccines are immunological products designed to protect pigs from infectious diseases, enhancing their health, productivity, and welfare. These animal vaccines stimulate the pig's immune system to develop immunity against specific pathogens, preventing outbreaks and reducing economic losses in the swine industry. Commonly targeted diseases include Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Type 2 (PCV2), and swine influenza. Swine vaccines are essential tools in veterinary medicine, ensuring the sustainability and biosecurity of pig farming operations.
Swine Vaccines Market Trends
Swine Vaccines Market Analysis
Based on product, the market is segmented into inactivated vaccines, live attenuated vaccines, recombinant vaccines, subunit vaccines, toxoid vaccines, and other products. The inactivated vaccines segment accounted for USD 568.4 million in 2023 in the global market.
Based on disease type, the swine vaccines market is classified into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus type 2 (PCV2), mycoplasma hyopneumoniae, classical swine fever (CSF), swine influenza, erysipelas, foot-and-mouth disease (FMD), African swine fever (ASF), porcine parvovirus, and other disease types. The porcine reproductive and respiratory syndrome (PRRS) segment held highest market share of 17.8% in 2023.
Based on end-user, the swine vaccines market is categorized into veterinary hospitals & clinics, swine farms, and research institutes. The veterinary hospitals & clinics segment dominated the global market and is poised to grow at 5% CAGR.
In 2023, the North American swine vaccines market was valued at USD 633.6 million and is expected to grow at a CAGR of 5.1% from 2024 to 2032.
The U.S. swine vaccines market, which accounted for USD 583.6 million in 2023, is projected to reach USD 893.6 million by 2032.
The swine vaccines market in China is set for remarkable growth in the coming years.
India is anticipated to grow at a considerable rate in the global swine vaccines market.
Swine Vaccines Market Share
The market is characterized by a competitive landscape with several key players vying for market share. Companies such as Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco, and Merck & Co., Inc. are prominent in the market, leveraging extensive R&D investments to develop advanced vaccines. These companies focus on expanding their product portfolios to address a wide range of swine diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Foot-and-Mouth Disease (FMD).
Swine Vaccines Market Companies
Prominent players operating in the swine vaccines industry include:
Swine Vaccines Industry News:
The swine vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Disease Type
Market, By End-user
The above information is provided for the following regions and countries: